TY  - JOUR
AU  - Denis, Marc G.
AU  - Herbreteau, Guillaume
AU  - Pons-Tostivint, Elvire
PY  - 2023
TI  - Molecular minimal residual disease in resected non-small cell lung cancer (NSCLC): results of specifically designed interventional clinical trials eagerly awaited
JF  - Translational Lung Cancer Research; Vol 12, No 2 (February 28, 2023): Translational Lung Cancer Research
Y2  - 2023
KW  - 
N2  - 
UR  - https://tlcr.amegroups.org/article/view/71769